Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: J Invest Dermatol. 2016 Mar 25;136(7):1429–1437. doi: 10.1016/j.jid.2016.03.019

Figure 5.

Figure 5

Increased incidence and higher mortality in Stat6VT x Kit +/W-sh and Stat6VT x Kit W-sh/W-sh mice. A, Percent of mice that develop no disease, mild disease or severe disease in mice of the indicated genotypes. Data were analyzed by Chi-square test ** p < 0.0001, n=13–24. B, The average age of development of severe disease in months is indicated in mice of the respective genotypes. Data are the mean ± SEM of 22–24 mice per group and were analyzed with student’s t-test. * p < 0.05 C, Morbidity curves of the indicated genotypes by Kaplan-Meier analysis, n=8–10/group.

HHS Vulnerability Disclosure